Botti H - Search Results

1

Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.

López GV, Batthyány C, Blanco F, Botti H, Trostchansky A, Migliaro E, Radi R, González M, Cerecetto H, Rubbo H. López GV, et al. Among authors: botti h. Bioorg Med Chem. 2005 Oct 15;13(20):5787-96. doi: 10.1016/j.bmc.2005.05.060. Bioorg Med Chem. 2005. PMID: 15993614

2

Interactions of nitric oxide and peroxynitrite with low-density lipoprotein.

Rubbo H, Trostchansky A, Botti H, Batthyány C. Rubbo H, et al. Among authors: botti h. Biol Chem. 2002 Mar-Apr;383(3-4):547-52. doi: 10.1515/BC.2002.055. Biol Chem. 2002. PMID: 12033442 Review.

3

Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein.

Möller M, Botti H, Batthyany C, Rubbo H, Radi R, Denicola A. Möller M, et al. Among authors: botti h. J Biol Chem. 2005 Mar 11;280(10):8850-4. doi: 10.1074/jbc.M413699200. Epub 2005 Jan 4. J Biol Chem. 2005. PMID: 15632138 Free article.

4

Reactivity of peroxynitrite and nitric oxide with LDL.

Botti H, Trostchansky A, Batthyány C, Rubbo H. Botti H, et al. IUBMB Life. 2005 Jun;57(6):407-12. doi: 10.1080/15216540500137701. IUBMB Life. 2005. PMID: 16012049 Free article. Review.

5

Genetic toxicology and preliminary in vivo studies of nitric oxide donor tocopherol analogs as potential new class of antiatherogenic agents.

Cabrera M, López GV, Gómez LE, Breijo M, Pintos C, Botti H, Raymondo S, Vettorazzi A, Ceráin AL, Monge A, Rubbo H, González M, Cerecetto H. Cabrera M, et al. Among authors: botti h. Drug Chem Toxicol. 2011 Jul;34(3):285-93. doi: 10.3109/01480545.2010.536769. Drug Chem Toxicol. 2011. PMID: 21649483

6

Antioxidant and diffusion properties of nitric oxide in low-density lipoprotein.

Rubbo H, Botti H, Batthyány C, Trostchansky A, Denicola A, Radi R. Rubbo H, et al. Among authors: botti h. Methods Enzymol. 2002;359:200-9. doi: 10.1016/s0076-6879(02)59184-9. Methods Enzymol. 2002. PMID: 12481572 No abstract available.

7

Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid.

Trostchansky A, Ferrer-Sueta G, Batthyány C, Botti H, Batinić-Haberle I, Radi R, Rubbo H. Trostchansky A, et al. Among authors: botti h. Free Radic Biol Med. 2003 Nov 15;35(10):1293-300. doi: 10.1016/j.freeradbiomed.2003.07.004. Free Radic Biol Med. 2003. PMID: 14607528

8

Peroxynitrite-mediated alpha-tocopherol oxidation in low-density lipoprotein: a mechanistic approach.

Botti H, Batthyány C, Trostchansky A, Radi R, Freeman BA, Rubbo H. Botti H, et al. Free Radic Biol Med. 2004 Jan 15;36(2):152-62. doi: 10.1016/j.freeradbiomed.2003.10.006. Free Radic Biol Med. 2004. PMID: 14744627

9

Nitric oxide inhibits prooxidant actions of uric acid during copper-mediated LDL oxidation.

Sanguinetti SM, Batthyány C, Trostchansky A, Botti H, López GI, Wikinski RL, Rubbo H, Schreier LE. Sanguinetti SM, et al. Among authors: botti h. Arch Biochem Biophys. 2004 Mar 15;423(2):302-8. doi: 10.1016/j.abb.2003.12.034. Arch Biochem Biophys. 2004. PMID: 15001394

10

Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition.

Nin N, Cassina A, Boggia J, Alfonso E, Botti H, Peluffo G, Trostchansky A, Batthyány C, Radi R, Rubbo H, Hurtado FJ. Nin N, et al. Among authors: botti h. Intensive Care Med. 2004 Dec;30(12):2271-8. doi: 10.1007/s00134-004-2427-x. Epub 2004 Sep 2. Intensive Care Med. 2004. PMID: 15349724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters